The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
Abstract
Inhibition of the activity of the human bile salt export pump (BSEP: ABCB11) has been proposed to play a role in drug-induced liver injury (DILI). To enhance understanding of the relationship between BSEP inhibition and DILI, inhibition of human BSEP (hBSEP) and its rat ortholog (rBsep) by 85 pharmaceuticals was investigated in vitro. This was explored using assays that quantified inhibition of ATP-dependent [(3)H]taurocholate uptake into inverted plasma membrane vesicles from Sf21 insect cells, which expressed the proteins. Of the pharmaceuticals, 40 exhibited evidence of in vitro transporter inhibition and overall a close correlation was observed between potency values for inhibition of hBSEP and rBsep activity (r(2) = 0.94), although 12 drugs exhibited >2-fold more potent inhibition of hBSEP than rBsep. The median potency of hBSEP inhibition was higher among drugs that caused cholestatic/mixed DILI than among drugs that caused hepatocellular or no DILI, as was the incidence of hBSEP inhibition with IC(50) <300 μM. All drugs with hBSEP IC(50) <300 μM had molecular weight >250, ClogP >1.5, and nonpolar surface area >180Å. A clear distinction was not evident between hBSEP IC(50) or unbound plasma concentration (C(max, u)) of the drugs in humans and whether the drugs caused DILI. However, all 17 of the drugs with hBSEP IC(50) <100 μM and C(max, u) >0.002 μM caused DILI. Overall, these data indicate that inhibition of hBSEP/rBsep correlates with the propensity of numerous pharmaceuticals to cause cholestatic DILI in humans and is associated with several of their physicochemical properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Bile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Hepatotoxicity the adverse effects of drugs and other chemicals on the liver
Zimmerman, H. J. (1999) · Cited by 514
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Kartenbeck, J., Leuschner, U., Mayer, R., & Keppler, D. (1996) · Hepatology · doi:10.1002/hep.510230519 · Cited by 398
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Mechanistic diversity in ATP-binding cassette (ABC) transporters.
Locher, K. P. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3216 · Cited by 804
The determination and interpretation of the therapeutic index in drug development
Muller, P. Y., & Milton, M. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3801 · Cited by 563
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
Hillgren, K. M., Keppler, D., Zur, A. A., Giacomini, K. M., Stieger, B., Cass, C. E., & Zhang, L. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.74 · Cited by 352
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337
Mechanisms of drug-induced liver injury
Yuan, L., & Kaplowitz, N. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.002 · Cited by 322
In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
Brouwer, K. L. R., Keppler, D., Hoffmaster, K. A., Bow, D. A. J., Cheng, Y., Lai, Y., Palm, J. E., Stieger, B., & Evers, R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.81 · Cited by 267
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges
Montanari, F., & Ecker, G. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.001 · Cited by 257
Animal models to study bile acid metabolism
Li, J., & Dawson, P. A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.011 · Cited by 255
Weaver, R. J., Blomme, E. A., Chadwick, A. E., Copple, I. M., Gerets, H. H. J., Goldring, C. E., Guillouzo, A., Hewitt, P. G., Ingelman-Sundberg, M., Jensen, K. G., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0048-x · Cited by 249
Role of endoplasmic reticulum stress in drug‐induced toxicity
Foufelle, F., & Fromenty, B. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.211 · Cited by 246
Morgan, R. E., van Staden, C. J., Chen, Y., Kalyanaraman, N., Kalanzi, J., Dunn, R. T., Afshari, C. A., & Hamadeh, H. K. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft176 · Cited by 243
Chu, X., Korzekwa, K., Elsby, R., Fenner, K., Galetin, A., Lai, Y., Matsson, P., Moss, A., Nagar, S., Rosania, G. R., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.78 · Cited by 236
Aleo, M. D., Luo, Y., Swiss, R., Bonin, P. D., Potter, D. M., & Will, Y. (2014) · Hepatology · doi:10.1002/hep.27206 · Cited by 215
Thompson, R. A., Isin, E. M., Li, Y., Weidolf, L., Page, K., Wilson, I., Swallow, S., Middleton, B., Stahl, S., Foster, A. J., et al. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300091x · Cited by 213
Self-citationUse of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans
Khetani, S. R., Kanchagar, C., Ukairo, O., Krzyzewski, S., Moore, A., Shi, J., Aoyama, S., Aleo, M., & Will, Y. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs326 · Cited by 208
Toxicology Strategies for Drug Discovery: Present and Future
Blomme, E. A. G., & Will, Y. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00407 · Cited by 194
The bile salt export pump (BSEP) in health and disease
Kubitz, R., Dröge, C., Stindt, J., Weissenberger, K., & Häussinger, D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.06.006 · Cited by 186
Pedersen, J. M., Matsson, P., Bergström, C. A. S., Hoogstraate, J. A., Norén, A., LeCluyse, E. L., & Artursson, P. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft197 · Cited by 162
Köck, K., Ferslew, B. C., Netterberg, I., Yang, K., Urban, T. J., Swaan, P. W., Stewart, P. W., & Brouwer, K. L. R. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054304 · Cited by 159
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016) · Scientific Reports · doi:10.1038/srep35434 · Cited by 156
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments
Thompson, R. A., Isin, E. M., Ogese, M. O., Mettetal, J. T., & Williams, D. P. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00410 · Cited by 154
Shah, F., Leung, L., Barton, H. A., Will, Y., Rodrigues, A. D., Greene, N., & Aleo, M. D. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv152 · Cited by 148
Vinken, M., Landesmann, B., Γούμενου, Μ., Vinken, S., Shah, I., Jaeschke, H., Willett, C., Whelan, M., & Rogiers, V. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft177 · Cited by 143
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury
Ortega‐Alonso, A., Stephens, C. M., Lucena, M. I., & Andrade, R. J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050714 · Cited by 140
Bruyn, T. D., Chatterjee, S., Fattah, S., Keemink, J., Nicolaï, J., Augustijns, P., & Annaert, P. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.773973 · Cited by 138
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies
Norman, B. H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00524 · Cited by 133
Guo, Y., Chu, X., Parrott, N. J., Brouwer, K. L. R., Hsu, V., Nagar, S., Matsson, P., Sharma, P. K., Snoeys, J., Sugiyama, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1183 · Cited by 132
Kenna, J. G., Taskar, K. S., Battista, C., Bourdet, D. L., Brouwer, K. L. R., Brouwer, K. R., Dai, D., Funk, C., Hafey, M. J., Lai, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1222 · Cited by 130
Self-citationThe physiological role of drug transporters
Liang, Y., Li, S., & Chen, L. (2015) · Protein & Cell · doi:10.1007/s13238-015-0148-2 · Cited by 130
Yang, K., Köck, K., Sedykh, A., Tropsha, A., & Brouwer, K. L. R. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23584 · Cited by 125
Predicting Drug-Induced Liver Injury with Bayesian Machine Learning
Williams, D. P., Lazic, S. E., Foster, A. J., Semenova, E., & Morgan, P. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00264 · Cited by 124
Membrane Transporters in Drug Development
Keogh, J. P. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-398339-8.00001-x · Cited by 121
A high content screening assay to predict human drug-induced liver injury during drug discovery
Persson, M., Løye, A. F., Mow, T. J., & Hornberg, J. J. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.08.001 · Cited by 120
Rodrigues, A. D., Lai, Y., Cvijic, M. E., Elkin, L. L., Zvyaga, T. A., & Soars, M. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054205 · Cited by 113
Liu, Y., Wen, P., Zhang, X., Dai, Y., & He, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3651 · Cited by 112
Soroka, C. J., & Boyer, J. L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.05.001 · Cited by 112
Li, T., Tong, W., Roberts, R. A., Liu, Z., & Thakkar, S. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00374 · Cited by 108
Lassila, T., Hokkanen, J., Aatsinki, S., Mattila, S., Turpeinen, M., & Tolonen, A. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00315 · Cited by 108
Sharanek, A., Burban, A., Burbank, M., Guével, R. L., Li, R., Guillouzo, A., & Guguen‐Guillouzo, C. (2016) · Scientific Reports · doi:10.1038/srep24709 · Cited by 102
Yang, K., Woodhead, J. L., Watkins, P. B., Howell, B. A., & Brouwer, K. L. R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.158 · Cited by 100
Walker, P., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02763-w · Cited by 99
Hepatocyte-based in vitro model for assessment of drug-induced cholestasis
Chatterjee, S., Richert, L., Augustijns, P., & Annaert, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.032 · Cited by 99
Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury
Woodhead, J. L., Yang, K., Siler, S. Q., Watkins, P. B., Brouwer, K. L. R., Barton, H. A., & Howell, B. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00240 · Cited by 98
Garside, H., Marcoe, K. F., Chesnut-Speelman, J., Foster, A. J., Muthas, D., Gerry Kenna, J., Warrior, U., Bowes, J., & Baumgartner, J. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.10.015 · Cited by 93
Self-citationPredicting drug-induced liver injury: The importance of data curation
Kotsampasakou, E., Montanari, F., & Ecker, G. F. (2017) · Toxicology · doi:10.1016/j.tox.2017.06.003 · Cited by 93
Warner, D. J., Chen, H., Cantin, L., Kenna, J. G., Stahl, S. H., Walker, C., & Noeske, T. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.047068 · Cited by 93
Self-citationMechanisms of Drug-Induced Hepatotoxicity
Shehu, A. I., Ma, X., & Venkataramanan, R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.002 · Cited by 92
Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury
Yang, K., Guo, C., Woodhead, J. L., Claire, R. L. S., Watkins, P. B., Siler, S. Q., Howell, B. A., & Brouwer, K. L. R. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.008 · Cited by 90
Minimizing DILI risk in drug discovery — A screening tool for drug candidates
Schadt, S., Simon, S., Kustermann, S., Boess, F., McGinnis, C., Brink, A., Lieven, R., Fowler, S., Youdim, K., Ullah, M., et al. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.09.019 · Cited by 89
Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics
Jani, M., Temesszentandrási‐Ambrus, C., Magnan, R., Jakab, K. T., Beéry, E., Zolnerciks, J. K., & Krajcsi, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1224-8 · Cited by 86
Ietswaart, R., Arat, S., Chen, A. X., Farahmand, S., Kim, B., DuMouchel, W., Armstrong, D., Fekete, A., Sutherland, J. J., & Urbán, L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102837 · Cited by 85
Role of Hepatic Efflux Transporters in Regulating Systemic and Hepatocyte Exposure to Xenobiotics
Pfeifer, N. D., Hardwick, R. N., & Brouwer, K. L. R. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140021 · Cited by 82
The Role of Bile Salt Export Pump Gene Repression in Drug-Induced Cholestatic Liver Toxicity
Garzel, B., Yang, H., Zhang, L., Huang, S. M., Polli, J. E., & Wang, H. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054189 · Cited by 82
The Role of Canalicular ABC Transporters in Cholestasis
Cuperus, F. J. C., Claudel, T., Gautherot, J., Halilbasic, E., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056358 · Cited by 81
Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis
Tolosa, L., Gómez‐Lechón, M. J., Jiménez, N., Hervás, D., Jover, R., & Donato, M. T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.04.007 · Cited by 81
Wink, S., Hiemstra, S. W., Huppelschoten, S., Klip, J. E., & van de Water, B. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2178-z · Cited by 80
Gustafsson, F., Foster, A. J., Sarda, S., Bridgland-Taylor, M. H., & Kenna, J. G. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft223 · Cited by 77
Self-citationShoda, L. K. M., Woodhead, J. L., Siler, S. Q., Watkins, P. B., & Howell, B. A. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1878 · Cited by 75
Kubitz, R., Dröge, C., Kluge, S., Stroß, C., Walter, N., Keitel, V., Häussinger, D., & Stindt, J. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8457-4 · Cited by 73
Role of enterohepatic recirculation in drug disposition: cooperation and complications
Malik, M. Y., Jaiswal, S., Sharma, A., Shukla, M. K., & Lal, J. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2016.1157600 · Cited by 71
Mechanisms of drug induced liver injury
Skat‐Rørdam, J., Lykkesfeldt, J., Gluud, L. L., & Tveden‐Nyborg, P. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05744-3 · Cited by 69
Burbank, M., Burban, A., Sharanek, A., Weaver, R. J., Guguen‐Guillouzo, C., & Guillouzo, A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071373 · Cited by 69
Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI
Chan, R., & Benet, L. Z. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx284 · Cited by 69
Current limitations and future opportunities for prediction of DILI from in vitro
Funk, C., & Roth, A. B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1874-9 · Cited by 67
Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
Weber, S., & Gerbes, A. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116049 · Cited by 67
Atienzar, F., Blomme, E. A. G., Chen, M., Hewitt, P. G., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter‐Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 66
Self-citationDrug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes
Oorts, M., Baze, A., Bachellier, P., Heyd, B., Zacharias, T., Annaert, P., & Richert, L. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.03.008 · Cited by 66
The right compound in the right assay at the right time: an integrated discovery DMPK strategy
Ballard, P. G., Brassil, P. J., Bui, K., Dolgos, H., Petersson, C., Tunek, A., & Webborn, P. J. H. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.691099 · Cited by 64
Hunt, C. M., Yuen, N., Stirnadel-Farrant, H. A., & Suzuki, A. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.09.007 · Cited by 64
High-content screening technology for studying drug-induced hepatotoxicity in cell models
Tolosa, L., Gómez‐Lechón, M. J., & Donato, M. T. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1503-z · Cited by 64
BSEP inhibition – In vitro screens to assess cholestatic potential of drugs
Kis, E., Ioja, E., Rajnai, Z., Jani, M., Méhn, D., Herédi‐Szabó, K., & Krajcsi, P. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.11.002 · Cited by 64
Cheng, P. T. W., Kaltenbach, R. F., Zhang, H., Shi, J., Tao, S., Li, J., Kennedy, L. J., Walker, S. J., Shi, Y., Wang, Y., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01256 · Cited by 61
Kaplowitz, N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00001-7 · Cited by 61
Species differences in bile acids II. Bile acid metabolism
Thakare, R. N., Alamoudi, J. A., Gautam, N., Rodrigues, A. D., & Alnouti, Y. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3645 · Cited by 61
Secondary pharmacology: screening and interpretation of off-target activities – focus on translation
Whitebread, S., Dumotier, B. M., Armstrong, D., Fekete, A., Chen, S., Hartmann, A., Muller, P. Y., & Urbán, L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.021 · Cited by 60
Dragović, S., Vermeulen, N. P. E., Gerets, H. H. J., Hewitt, P. G., Ingelman‐Sundberg, M., Park, B. K., Juhila, S., Snoeys, J., & Weaver, R. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1845-1 · Cited by 59
Nayagam, J. S., Williamson, C., Joshi, D., & Thompson, R. J. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16118 · Cited by 58
The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury
Amacher, D. E. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.658041 · Cited by 58
Atienzar, F., Novik, E., Gerets, H. H. J., Parekh, A., Delatour, C., Cardenas, A., MacDonald, J. S., Yarmush, M. L., & Dhalluin, S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.022 · Cited by 58
Aleo, M. D., Shah, F., Allen, S. W., Barton, H. A., Costales, C., Lazzaro, S., Leung, L. Y., Nilson, A. L., Obach, R. S., Rodrigues, A. D., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00262 · Cited by 58
Avoiding idiosyncratic DILI: Two is better than one
Kaplowitz, N. (2013) · Hepatology · doi:10.1002/hep.26295 · Cited by 58
Assessment of gadoxetate DCE‐MRI as a biomarker of hepatobiliary transporter inhibition
Ulloa, J. L., Stahl, S. H., Yates, J. W. T., Woodhouse, N., Kenna, J. G., Jones, H. B., Waterton, J. C., & Hockings, P. D. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2946 · Cited by 57
Self-citationYang, K., Pfeifer, N. D., Köck, K., & Brouwer, K. L. R. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221564 · Cited by 57
Hiemstra, S. W., Ramaiahgari, S., Wink, S., Callegaro, G., Coonen, M. L. J., Meerman, J. H. N., Jennen, D. G. J., van den Nieuwendijk, K., Dankers, A. C. A., Snoeys, J., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02552-0 · Cited by 57
Kotsampasakou, E., & Ecker, G. F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00518 · Cited by 56
Tian, J., Zhu, J., Yi, Y., Li, C., Zhang, Y., Zhao, Y., Chen, P., Xiang, S., Li, X., Li, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09131-2 · Cited by 56
Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function
Telbisz, Á., & Homolya, L. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1102889 · Cited by 55
Malinen, M. M., Ali, I., Tiley, J. B., Beaudoin, J. J., & Brouwer, K. L. R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00310.2017 · Cited by 55
Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Roth, A. D., & Lee, M. (2017) · BioMed Research International · doi:10.1155/2017/9176937 · Cited by 54
Persson, M., Løye, A. F., Jacquet, M., Mow, N. S., Thougaard, A., Mow, T. J., & Hornberg, J. J. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12200 · Cited by 53
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury
Gijbels, E., Vilas‐Boas, V., Annaert, P., Vanhaecke, T., Devisscher, L., & Vinken, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02691-9 · Cited by 51
Ulzurrun, E., Stephens, C. M., Crespo, E., Ruiz‐Cabello, F., Ruiz‐Nuñez, J., Sáenz-López, P., Moreno‐Herrera, I., Robles‐Díaz, M., Hallal, H., Planas, J. M. M., et al. (2013) · Liver International · doi:10.1111/liv.12193 · Cited by 50
Zhang, J., He, K., Cai, L., Chen, Y., Yang, Y., Shi, Q., Woolf, T. F., Ge, W., Guo, L., Borlak, J. T., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.03.019 · Cited by 49
Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis
Mahdi, Z., Synal-Hermanns, U., Yoker, A., Locher, K. P., & Stieger, B. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103390 · Cited by 49
Wolenski, F. S., Zhu, A. Z. X., Johnson, M., Yu, S., Moriya, Y., Ebihara, T., Csizmadia, V., Grieves, J. L., Paton, M., Liao, M., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx018 · Cited by 49
Kenna, J. G., Stahl, S. H., Eakins, J. A., Foster, A. J., Andersson, L. C., Bergare, J., Billger, M., Elebring, M., Elmore, C. S., & Thompson, R. A. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220491 · Cited by 48
Self-citation
Metadata
- Authors
- Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 40
- Issue
- 1
- Pages
- 130-138
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2134837921
- Semantic Scholar
- 60ba71aac3cdfdcd69699825099b32f2949b1f89
- Cited by
- 343
- References
- 49
- Citations by year
- 2026: 18 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 25 · 2017: 43 · 2016: 40 · 2015: 27 · 2014: 28 · 2013: 35 · 2012: 13
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Drug Metabolism and Disposition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- bile salt export pump, ABCB11, drug-induced liver injury, cholestatic liver injury, transporter inhibition, taurocholate uptake, physicochemical properties, drug safety prediction, hepatotoxicity
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily B, Member 11, Animals, Bile Acids and Salts, Cell Line, Cholestasis, Humans, Insecta, Risk Factors, ATP-Binding Cassette Transporters, Rats, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.